Responsibilities
- Own pipeline and product communications for one or more RAS(ON) inhibitors or tumor types, ensuring clear differentiation, scientific credibility, and alignment with overall corporate and pipeline strategy
- Lead communications execution for clinical milestones, including data readouts, abstracts, presentations, and major medical congresses
- Partner with R&D and Medical Affairs to translate complex clinical and scientific data into clear, compelling external messaging tailored to the tumor-specific audience
- Partner with affiliate communications teams in ex-U.S. markets to align on communications strategy and ensure globally consistent, locally relevant execution across key pipeline and product milestones
- Support regulatory and pre-launch communications, including trial initiations, regulatory submissions, approvals, and launch readiness activities
- Execute disease awareness and patient advocacy communications in partnership with Patient Advocacy, ensuring responsible education and inclusion of patient voice
- Support communications related to value, access, and product-specific issues, in coordination with Market Access, Legal, and Corporate Communications
- Contribute to scientific and medical thought leadership efforts, including congress presence, publication support, speaker positioning, and external engagement
- In partnership with Corporate Communications, support earned media efforts for industry, trade, and scientific publications tied to tumor-specific milestones
- Manage agency partners and external vendors supporting the tumor-specific communications program, ensuring quality execution and alignment with strategy